Pharmaniaga posts RM607m net loss in FY2022, triggers PN17 criteria
KUALA LUMPUR, Feb 28 — Pharmaniaga Bhd has posted a net loss of RM607.32 million for the financial year ended December 31, 2022 (FY2022) against a net profit of RM172.15 million...
Stay updated with breaking news from Practice Note. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KUALA LUMPUR, Feb 28 — Pharmaniaga Bhd has posted a net loss of RM607.32 million for the financial year ended December 31, 2022 (FY2022) against a net profit of RM172.15 million...
KUALA LUMPUR: Shares in Pharmaniaga Bhd plunged 50% or 22 sen to 22 sen a share at the opening bell, following news the company had slipped into Practice Note 17 (PN17) status.
PETALING JAYA: Pharmaniaga Bhd has been classified as an affected listed issuer under Practice Note 17 (PN17) of the Main Market Listing Requirements of Bursa Malaysia.
PETALING JAYA: Pharmaniaga Bhd has been classified as an affected listed issuer under Practice Note 17 (PN17) of the Main Market Listing Requirements of Bursa Malaysia.
An outline and analysis of the South African National Budget Speech, delivered on Wednesday 22 February 2023 by Finance Minister Enoch Godongwana A. Corporate Tax